// App-Quantinova.ai

e14582 : Final results of a phase 1 trial of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors.

Researchers

Presenter

  • Abeer F Alharbi

Principal Investigators

  • Mark N. Kirstein

  • Naomi Fujioka

Medical Centers

  • Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN

  • College of Pharmacy and Masonic Cancer Center University of Minnesota, Minneapolis, MN

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Pemetrexed

  • Cisplatin

  • Sorafenib

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • I

Study Id's

  • NCT00703638

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved